id: NEW:combined_trauma_focused_and_pharmacotherapy_to_NEW:comorbid_ptsd_sud_outcomes
name: Combined Trauma-Focused Therapy and SUD Pharmacotherapy â†’ Comorbid PTSD and
  Substance Use Disorder Outcomes
from_node:
  node_id: NEW:combined_trauma_focused_and_pharmacotherapy
  node_name: Combined Trauma-Focused Therapy and SUD Pharmacotherapy
to_node:
  node_id: NEW:comorbid_ptsd_sud_outcomes
  node_name: Comorbid PTSD and Substance Use Disorder Outcomes
direction: negative
category: behavioral
mechanism_pathway:
- 'Step 1: Trauma-focused therapy (e.g., prolonged exposure, cognitive processing
  therapy) directly addresses PTSD symptoms by processing traumatic memories, reducing
  avoidance behaviors, and modifying maladaptive cognitions about the trauma'
- 'Step 2: Pharmacotherapy targeting substance use disorders (e.g., naltrexone, acamprosate)
  reduces craving, blocks rewarding effects of substances, and stabilizes neurobiological
  systems disrupted by chronic substance use'
- 'Step 3: The synergistic combination addresses the bidirectional relationship between
  PTSD and SUD - as trauma symptoms decrease, the need for substance use as self-medication
  diminishes; as substance use decreases, cognitive and emotional processing of trauma
  becomes more effective'
- 'Step 4: Combined treatment leads to sustained improvements in both PTSD severity
  and alcohol/drug use severity, with effects maintained at 12-month follow-up'
evidence:
  quality_rating: A
  n_studies: 36
  primary_citation: 'D. Hien et al. 2022. Project Harmony: A Meta-Analysis With Individual
    Patient Data on Behavioral and Pharmacologic Trials for Comorbid Posttraumatic
    Stress and Alcohol or Other Drug Use Disorders. American Journal of Psychiatry.'
  supporting_citations: []
description: Combining trauma-focused behavioral therapy with pharmacotherapy for
  substance use disorders produces the largest treatment effects for comorbid PTSD
  and SUD compared to treatment as usual. This meta-analysis of 36 trials (N=4,046)
  found large effect sizes for both PTSD severity (d=-0.92) and alcohol use severity
  (d=-1.10) at end of treatment, with improvements sustained at 12-month follow-up.
  The synergistic approach addresses both conditions simultaneously, breaking the
  cycle of trauma symptoms driving substance use and substance use impairing trauma
  processing.
last_updated: '2025-12-02'
extraction_method: consolidated_batch_v3
quantitative_effects:
  effect_size:
    value: -0.92
    type: cohens_d
    ci_lower: -1.57
    ci_upper: -0.3
  p_value: null
  sample_size: 4046
moderators:
- name: Outcome type
  direction: strengthens
  strength: strong
  description: Effect sizes were larger for alcohol use severity (d=-1.10) compared
    to PTSD severity (d=-0.92), suggesting the combination may be particularly effective
    for alcohol-related comorbidity
- name: Treatment timing
  direction: strengthens
  strength: moderate
  description: Early and sustained improvements observed, with effects maintained
    at 12-month follow-up
